Analytical solutions readily delivered

Discover how 2D-LC-MS supports monoclonal antibody clone selection in our newest publication

06/11/2017

The versatility of heart-cutting and comprehensive two-dimensional liquid chromatography in monoclonal antibody clone selection

Abstract

In recent years, two-dimensional liquid chromatography (2D-LC) has seen an enormous evolution and one of the fields where it is being widely adopted is in the analysis of therapeutic monoclonal antibodies (mAbs). We here further add to the many flavours of this powerful technology. Workflows based on heart-cutting (LC-LC) and comprehensive (LC×LC) 2D-LC are described that allow to guide the clone selection process in mAb and biosimilar development. Combining Protein A affinity chromatography in the first dimension with size exclusion (SEC), cation exchange (CEX) or reversed-phase liquid chromatography-mass spectrometry (RPLC-MS) in the second dimension simultaneously allows to assess mAb titer and critical structural aspects such as aggregation, fragmentation, charge heterogeneity, molecular weight (MW), amino acid sequence and glycosylation. Complementing the LC-LC measurements at intact protein level with LC×LC based peptide mapping provides the necessary information to make clear decisions on which clones to take further into development.

Copyright © 2017 Elsevier B.V. All rights reserved (link ncbi).

Read the whole article

1_s2_0_S0021967317309202_gr5_lrg